Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Patient
100%
Therapeutic Procedure
33%
Hospital
32%
COVID-19
29%
Diagnosis
25%
Antibiotics
24%
Physician
17%
Systematic Review
16%
Symptom
15%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Patient Referral
13%
Salmonella Enterica Serovar Paratyphi A
13%
Returning Traveler
13%
Adult
13%
Analysis
13%
Laboratory
12%
Antibiotic Therapy
11%
Low and Middle Income Countries
11%
Tropical Disease
10%
Traveler
10%
T-Cell Response
10%
Knowledge, Attitudes and Practices Survey
9%
Typhoid Fever
9%
Prognosis
9%
Intensive Care Unit
9%
Person
9%
Tuberculosis
8%
Genetics
8%
Case Finding
8%
Observational Study
8%
Pneumonia
8%
Case Report
8%
Patient Characteristics
8%
Tuberculostatic Agent
8%
Mixed Methods
8%
Disease Severity
8%
Serotype
8%
Bloodstream Infection
8%
Inhalation
8%
Strongyloidiasis
8%
Parenteral Drug Administration
8%
Pseudomonas aeruginosa
8%
Salmonella Enterica Subsp. Enterica
8%
Exhalation
8%
Magnetic Resonance Imaging
8%
Rapid Diagnostic Test
8%
Retrospective Cohort Study
8%
Antiinfective Agent
8%
Neurosyphilis
8%
Melioidosis
8%
Immunology and Microbiology
Infection
57%
Time
19%
Cytotoxic T-Cell
18%
Infectious Agent
18%
T Cell
17%
T Cell Receptor
16%
Infectious Disease
16%
Staphylococcus aureus
13%
Salmonella
13%
Susceptibility
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
COVID-19
11%
Epitope
11%
Klebsiella pneumoniae
10%
Leukocyte Count
9%
Polyinosinic:polycytidylic Acid
8%
Recognition
8%
Viral Disease
8%
Human Immunodeficiency Virus 1
8%
Coding
8%
Plasmodium falciparum
8%
Dendritic Cell
8%
Rabies Immunoglobulin
8%
Antibody Response
8%
Fever
8%
C-Reactive Protein
8%
Escherichia coli
8%
Antimicrobial Agent
8%
Rabies
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
36%
Drugs
18%
HIV
16%
Symptom
16%
Third Generation Cephalosporin
14%
Mortality
12%
Diseases
11%
Ciprofloxacin
11%
Observational Study
10%
Erythromycin
10%
Salmonella enterica
8%
Transcriptome
8%
Thrombin Activatable Fibrinolysis Inhibitor
8%
CD8 Antigen
8%
Treatment Group
8%
Inhalation
8%
Retrospective Study
8%
Acute Kidney Failure
8%
Cobicistat Plus Elvitegravir Plus Emtricitabine Plus Tenofovir Disoproxil
8%
Pravastatin
8%
Rhabdomyolysis
8%
Fenofibrate
8%
Infection
8%
Salmonella
8%
Antimicrobial Agent
8%
Bloodstream Infection
8%
Nicotinamide Phosphoribosyltransferase
6%
Corticosteroid
5%
Comorbidity
5%
